Market Research Logo

Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2017

Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Age-Related Macular Degeneration patients study in a new report ‘Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Age-Related Macular Degeneration epidemiology, Age-Related Macular Degeneration diagnosed patients, and Age-Related Macular Degeneration treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Age-Related Macular Degeneration derived from epidemiological analysis, percentage of patients diagnosed with Age-Related Macular Degeneration, and percentage of patients treated with a therapy.

The study helps executives estimate Age-Related Macular Degeneration market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Age-Related Macular Degeneration prevalence, Age-Related Macular Degeneration diagnosis rate, and Age-Related Macular Degeneration treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Age-Related Macular Degeneration Patient Flow
  • Age-Related Macular Degeneration Prevalence
  • Age-Related Macular Degeneration Diagnosed Patients
  • Age-Related Macular Degeneration Treated Patients


1. Age-Related Macular Degeneration: Disease Definition
2. Global Age-Related Macular Degeneration Patient Flow
2A. Global Age-Related Macular Degeneration Prevalence
2B. Global Age-Related Macular Degeneration Diagnosed Patients
2C. Global Age-Related Macular Degeneration Treated Patients
3. Age-Related Macular Degeneration Patient Flow in the US
3A. Age-Related Macular Degeneration Prevalence in the US
3B. Age-Related Macular Degeneration Diagnosed Patients in the US
3C. Age-Related Macular Degeneration Treated Patients in the US
4. Age-Related Macular Degeneration Patient Flow in Europe
4A. Age-Related Macular Degeneration Prevalence in Europe
4B. Age-Related Macular Degeneration Diagnosed Patients in Europe
4C. Age-Related Macular Degeneration Treated Patients in Europe
5. Age-Related Macular Degeneration Patient Flow in Germany
5A. Age-Related Macular Degeneration Prevalence in Germany
5B. Age-Related Macular Degeneration Diagnosed Patients in Germany
5C. Age-Related Macular Degeneration Treated Patients in Germany
6. Age-Related Macular Degeneration Patient Flow in France
6A. Age-Related Macular Degeneration Prevalence in France
6B. Age-Related Macular Degeneration Diagnosed Patients in France
6C. Age-Related Macular Degeneration Treated Patients in France
7. Age-Related Macular Degeneration Patient Flow in Spain
7A. Age-Related Macular Degeneration Prevalence in Spain
7B. Age-Related Macular Degeneration Diagnosed Patients in Spain
7C. Age-Related Macular Degeneration Treated Patients in Spain
8. Age-Related Macular Degeneration Patient Flow in Italy
8A. Age-Related Macular Degeneration Prevalence in Italy
8B. Age-Related Macular Degeneration Diagnosed Patients in Italy
8C. Age-Related Macular Degeneration Treated Patients in Italy
9. Age-Related Macular Degeneration Patient Flow in UK
9A. Age-Related Macular Degeneration Prevalence in UK
9B. Age-Related Macular Degeneration Diagnosed Patients in UK
9C. Age-Related Macular Degeneration Treated Patients in UK
10. Age-Related Macular Degeneration Patient Flow in Japan
10A. Age-Related Macular Degeneration Prevalence in Japan
10B. Age-Related Macular Degeneration Diagnosed Patients in Japan
10C. Age-Related Macular Degeneration Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Age-Related Macular Degeneration Patient Flow, 2016
Table 2: Global Age-Related Macular Degeneration Patient Flow Forecast, 2016 - 2025
Table 3: Age-Related Macular Degeneration Patient Flow in the US, 2016
Table 4: Age-Related Macular Degeneration Patient Flow Forecast in the US, 2016 - 2025
Table 5: Age-Related Macular Degeneration Patient Flow in Europe, 2016
Table 6: Age-Related Macular Degeneration Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Age-Related Macular Degeneration Patient Flow in Germany, 2016
Table 8: Age-Related Macular Degeneration Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Age-Related Macular Degeneration Patient Flow in France, 2016
Table 10: Age-Related Macular Degeneration Patient Flow Forecast in France, 2016 - 2025
Table 11: Age-Related Macular Degeneration Patient Flow in Spain, 2016
Table 12: Age-Related Macular Degeneration Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Age-Related Macular Degeneration Patient Flow in Italy, 2016
Table 14: Age-Related Macular Degeneration Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Age-Related Macular Degeneration Patient Flow in UK, 2016
Table 16: Age-Related Macular Degeneration Patient Flow Forecast in UK, 2016 - 2025
Table 17: Age-Related Macular Degeneration Patient Flow in Japan, 2016
Table 18: Age-Related Macular Degeneration Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Age-Related Macular Degeneration Patient Flow, 2016
Figure 2: Global Age-Related Macular Degeneration Patient Flow Forecast, 2016 - 2025
Figure 3: Age-Related Macular Degeneration Patient Flow in the US, 2016
Figure 4: Age-Related Macular Degeneration Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Age-Related Macular Degeneration Patient Flow in Europe, 2016
Figure 6: Age-Related Macular Degeneration Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Age-Related Macular Degeneration Patient Flow in Germany, 2016
Figure 8: Age-Related Macular Degeneration Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Age-Related Macular Degeneration Patient Flow in France, 2016
Figure 10: Age-Related Macular Degeneration Patient Flow Forecast in France, 2016 - 2025
Figure 11: Age-Related Macular Degeneration Patient Flow in Spain, 2016
Figure 12: Age-Related Macular Degeneration Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Age-Related Macular Degeneration Patient Flow in Italy, 2016
Figure 14: Age-Related Macular Degeneration Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Age-Related Macular Degeneration Patient Flow in UK, 2016
Figure 16: Age-Related Macular Degeneration Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Age-Related Macular Degeneration Patient Flow in Japan, 2016
Figure 18: Age-Related Macular Degeneration Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report